
Commentary|Videos|July 23, 2024
Dr Backhus on Surgical Eligibility in Borderline Resectable NSCLC
Author(s)Leah Backhus, MD, MPH, FACS
Fact checked by: Chris Ryan, Ashling Wahner
Leah Backhus, MD, MPH, FACS, discusses the evolving definition of surgical resectability in patients with borderline resectable NSCLC.
Advertisement
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto, discusses the evolving definition of surgical resectability in patients with borderline resectable non–small cell lung cancer (NSCLC).
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC
2
Oral Administration Afforded by CDK2 Inhibitors May Ease the Price of Admission in Platinum-Resistant Ovarian Cancer
3
MAIC Shows Improved PFS With Zanubrutinib Over Ibrutinib in Treatment-Naive CLL
4
Dr Randall on the Clinical Utility of Tumor-Informed ctDNA Deep Sequencing for Osteosarcoma Surveillance
5








































































